198 related articles for article (PubMed ID: 10814527)
1. Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells.
Mu YM; Yanase T; Nishi Y; Waseda N; Oda T; Tanaka A; Takayanagi R; Nawata H
Biochem Biophys Res Commun; 2000 May; 271(3):710-3. PubMed ID: 10814527
[TBL] [Abstract][Full Text] [Related]
2. Regulation of aromatase by nuclear receptors.
Yanase T; Mu YM; Nishi Y; Goto K; Nomura M; Okabe T; Takayanagi R; Nawata H
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):187-92. PubMed ID: 11850224
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment with specific ligands for PPARgamma:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells.
Mu YM; Yanase T; Nishi Y; Takayanagi R; Goto K; Nawata H
Mol Cell Endocrinol; 2001 Jul; 181(1-2):239-48. PubMed ID: 11476957
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor-gamma and retinoid X receptor inhibits aromatase transcription via nuclear factor-kappaB.
Fan W; Yanase T; Morinaga H; Mu YM; Nomura M; Okabe T; Goto K; Harada N; Nawata H
Endocrinology; 2005 Jan; 146(1):85-92. PubMed ID: 15459115
[TBL] [Abstract][Full Text] [Related]
5. A nuclear receptor system constituted by RAR and RXR induces aromatase activity in MCF-7 human breast cancer cells.
Mu YM; Yanase T; Nishi Y; Hirase N; Goto K; Takayanagi R; Nawata H
Mol Cell Endocrinol; 2000 Aug; 166(2):137-45. PubMed ID: 10996432
[TBL] [Abstract][Full Text] [Related]
6. Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose.
Rubin GL; Duong JH; Clyne CD; Speed CJ; Murata Y; Gong C; Simpson ER
Endocrinology; 2002 Aug; 143(8):2863-71. PubMed ID: 12130549
[TBL] [Abstract][Full Text] [Related]
7. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.
Cha BS; Ciaraldi TP; Carter L; Nikoulina SE; Mudaliar S; Mukherjee R; Paterniti JR; Henry RR
Diabetologia; 2001 Apr; 44(4):444-52. PubMed ID: 11357475
[TBL] [Abstract][Full Text] [Related]
10. Dual activation of PPARalpha and PPARgamma by mono-(2-ethylhexyl) phthalate in rat ovarian granulosa cells.
Lovekamp-Swan T; Jetten AM; Davis BJ
Mol Cell Endocrinol; 2003 Mar; 201(1-2):133-41. PubMed ID: 12706301
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma.
Hashimoto Y; Shimada Y; Itami A; Ito T; Kawamura J; Kawabe A; Kaganoi J; Maeda M; Watanabe G; Imamura M
Eur J Cancer; 2003 Oct; 39(15):2239-46. PubMed ID: 14522385
[TBL] [Abstract][Full Text] [Related]
12. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells.
Schoppee PD; Garmey JC; Veldhuis JD
Biol Reprod; 2002 Jan; 66(1):190-8. PubMed ID: 11751282
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
Fukunaga Y; Itoh H; Doi K; Tanaka T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Hosoda K; Kook H; Ueda M; Nakao K
Atherosclerosis; 2001 Sep; 158(1):113-9. PubMed ID: 11500181
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells.
Goetze S; Kim S; Xi XP; Graf K; Yang DC; Fleck E; Meehan WP; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 2000 May; 35(5):749-57. PubMed ID: 10813377
[TBL] [Abstract][Full Text] [Related]
15. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
[TBL] [Abstract][Full Text] [Related]
17. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]